Download 1 IN 5 PATIENTS MAY HARBOR DIAGNOSABLE MENTAL ILLNESS1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Reproductive health wikipedia , lookup

Patient safety wikipedia , lookup

Deinstitutionalisation wikipedia , lookup

Rhetoric of health and medicine wikipedia , lookup

Transcript
IT’S MORE COMMON THAN MOST REALIZE.
1 IN 5 PATIENTS MAY HARBOR DIAGNOSABLE MENTAL ILLNESS1
LabCorp can help you identify the patients that can benefit from treatment
M3 CHECKLIST:
A Multidimensional Screen for Depression, Anxiety, Bipolar
Disorder, and PTSD with an Option for Alcohol Misuse
MENTAL ILLNESS
IS COMMON
AND NEEDS TO BE TREATED AS
SERIOUSLY AS PHYSICAL ILLNESSES.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), any
mental illness (AMI) is defined as “currently or at any time in the past 12 months having
had a diagnosable mental, behavioral, or emotional disorder (excluding developmental and
substance use disorders) of sufficient duration to meet diagnostic criteria specified within the
DSM-IV.” 1
The first line of defense in mental health screening typically resides in a primary care setting.
The majority of mental health visits occur with primary care physicians, and these same
professionals write the bulk of antidepressant and antianxiety prescriptions for mood and
anxiety disorders.2
Routinely evaluating mental health within a primary care setting can be an effective way to
identify these disorders, leading to appropriate diagnoses and treatment. LabCorp is proud to
offer an efficient, time saving, and comprehensive tool for screening and monitoring of
these issues.
Nearly 43.6 million Americans, or 18.1% of
all adults, have dealt with such a disorder in
the past year.1 Of those, less than half receive
needed treatment.3
PHYSICIAN/PATIENT DATA FLOW
Physician can order and receive the M3
assessment report seamlessly over the
LabCorp infrastructure
START
Patient receives email
notifying them to take M3
Checklist assessment
Patient clicks on a secure
hyperlink inside email
Patient completes the 3-5
minute questionnaire
using web-enabled device
M3 Checklist Survey
Compilation and
Assessment
Results Delivered
Electronically to
Physician
Process Complete
Easy to Use
and
Mobile Friendly
An efficient and powerful tool.
Within about 30 seconds, most clinicians can review
and be prepared for a patient discussion
Jane Doe
03/26/1961 (Age 55)
0000000001
04:06 PM
Using the Physician/
Patient Data Flow
results flow into your system.
0000000001
PM
Optional AUDIT-C
Alcohol Risk
M3 CHECKLIST:
A MULTIDIMENSIONAL SCREEN FOR
DEPRESSION, ANXIETY, BIPOLAR
DISORDER AND PTSD
M3 Checklist’s benefit lies both within its simplicity and complexity.
Offered for the first time through LabCorp, M3 Checklist is a nationally-recognized, peerreviewed and clinically validated tool2 that compiles and evaluates a patient’s potential for
mood and anxiety symptoms using a secure web-based system.
Increase your confidence in your ability to detect and diagnose behavioral health concerns. A
study involving this checklist found the psychometric properties of the 27-item M3 Checklist
assessment tool compare favorably with those of currently-used single-disorder screening
tools.
For patients, an easy-to-use web-based questionnaire that assesses common indications
relating to mental health is completed within minutes. Those patient responses are compiled,
quantified, and calculated into an M3 Score and component subscores, offering an assessment
of an individual’s diagnosis risk: negative, low, medium, or high. This score is included in a
detailed M3 Checklist report that can then be used to help guide discussion with a patient
during a visit and/or to determine any needed action.
M3 Checklist offers other advantages beyond just depression screening:
•
•
•
•
Integrates screening for anxiety, bipolar disorder, and PTSD concerns.
Provides added detail to help determine severity and comorbid
psychological problems, as suggested by U.S. Preventive Services Task
Force.4
Optional assessment using the AUDIT-C for alcohol misuse available.
Secure, easy-to-use web- and mobile-friendly interface that take patients
mere minutes to complete.
LabCorp Test Ordering
TEST NO.
DESCRIPTION
819972
M3 Checklist
820102
AUDIT-C
820156
Panel with both M3 Checklist and AUDIT-C
Common Procedural Codes
CPT Code
CPT Definition
Non-facility - National
Facility - National
96160
Administration of patient-focused health risk assessment instrument
(eg, health hazard appraisal) with scoring and documentation, per
standardized instrument
$4.67
N/A
96161
Administration of caregiver-focused health risk assessment
instrument (eg, depression inventory) for the benefit of the patient,
with scoring and documentation, per standardized instrument
$4.67
N/A
G0444
Annual depression screening, 15 minutes
$18.30
$9.69
G0442
Annual alcohol misuse screening, 15 minutes
$18.30
$9.69
G0443
Brief face-to-face behavioral counseling for alcohol misuse, 15
minutes
$26.20
$24.05
99408
Alcohol and/or substance (other than tobacco) abuse structured
screening (eg, AUDIT, DAST), and brief intervention (SBI) services; 15
to 30 minutes
$33.74
$35.53
96103
Psychological testing (includes psychodiagnostic assessment of
emotionality, intellectual abilities, personality and psychopathology,
eg, MMPI), administered by a computer, with qualified health care
professional interpretation and report
$26.92
$27.99
DISCLAIMER: M3 Checklist assessment, when combined with physician review and patient discussion, may be eligible for reimbursement depending on
services provided. Not all codes may be accepted by payers. Reimbursement requires use of appropriate billing code, diagnostic code and, in some cases,
appropriate modifier. CPT® codes included for informational purposes only and not intended as specific diagnostic/coding. Current Procedural Terminology
(CPT®) copyright 2016 American Medical Association. All Rights Reserved. CPT is a registered trademark of the American Medical Association.
M3 Checklist was developed by M3 Information, and the assessment is made available through LabCorp, its exclusive US distributor.
References
1. Center for Behavioral Health Statistics and Quality (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use
and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data.
2. Gaynes BN, et al. Feasibility and Diagnostic Validity of the M-3 Checklist: A Brief, Self-Rated Screen for Depressive, Bipolar, Anxiety, and Post-Traumatic Stress
Disorders in Primary Care. Ann Fam Med 2010;8:160-169.doi:10.1370/afm.1092.
3. Mental Health Myths and Facts. U.S. Department of Health & Human Services website http://www.mentalhealth.gov/basics/myths-facts/index.html .
Updated November 13, 2015. Accessed March 2, 2012.
4. Siu AL. Screening for Depression in Adults: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2016;315(4):380-387.
©2017 Laboratory Corporation of America® Holdings All rights reserved. L15034-0417-3